[Basal ganglia lesions and neurotransmitters].
D000109:Acetylcholine / Q000378:metabolism; D000818:Animals; D001479:Basal Ganglia / Q000378:metabolism / Q000503:physiopathology*; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy; D018377:Neurotransmitter Agents / Q000502:physiology*; D010300:Parkinson Disease / Q000503:physiopathology*; D011817:Rabbits; D051381:Rats; D013373:Substance P / Q000502:physiology; D013378:Substantia Nigra / Q000503:physiopathology; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use
D018377:Neurotransmitter Agents; D013373:Substance P; D005680:gamma-Aminobutyric Acid; D000109:Acetylcholine; D004298:Dopamine